Johnson & Johnson (JNJ)
267.12
+1.35
(+0.51%)
USD |
NYSE |
Aug 28, 15:29
Johnson & Johnson Total Liabilities (Quarterly) : 116.09B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 116.09B |
| March 31, 2026 | 119.71B |
| December 31, 2025 | 117.67B |
| September 30, 2025 | 113.54B |
| June 30, 2025 | 114.92B |
| March 31, 2025 | 115.56B |
| December 31, 2024 | 108.61B |
| September 30, 2024 | 108.13B |
| June 30, 2024 | 109.55B |
| March 31, 2024 | 101.95B |
| December 31, 2023 | 98.78B |
| September 30, 2023 | 94.83B |
| June 30, 2023 | 115.28B |
| March 31, 2023 | 125.10B |
| December 31, 2022 | 110.57B |
| September 30, 2022 | 100.52B |
| June 30, 2022 | 101.37B |
| March 31, 2022 | 103.65B |
| December 31, 2021 | 108.00B |
| September 30, 2021 | 108.96B |
| June 30, 2021 | 106.86B |
| March 31, 2021 | 106.72B |
| December 31, 2020 | 111.62B |
| September 30, 2020 | 106.22B |
| June 30, 2020 | 95.40B |
| Date | Value |
|---|---|
| March 31, 2020 | 93.72B |
| December 31, 2019 | 98.26B |
| September 30, 2019 | 97.31B |
| June 30, 2019 | 94.33B |
| March 31, 2019 | 91.07B |
| December 31, 2018 | 93.20B |
| September 30, 2018 | 91.08B |
| June 30, 2018 | 92.48B |
| March 31, 2018 | 93.37B |
| December 31, 2017 | 97.14B |
| September 30, 2017 | 81.68B |
| June 30, 2017 | 80.88B |
| March 31, 2017 | 74.58B |
| December 31, 2016 | 70.79B |
| September 30, 2016 | 67.60B |
| June 30, 2016 | 67.34B |
| March 31, 2016 | 63.58B |
| December 31, 2015 | 62.26B |
| September 30, 2015 | 61.71B |
| June 30, 2015 | 60.90B |
| March 31, 2015 | 60.71B |
| December 31, 2014 | 61.37B |
| September 30, 2014 | 55.51B |
| June 30, 2014 | 57.15B |
| March 31, 2014 | 56.75B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
| Pfizer Inc. | 115.64B |
| Bristol Myers Squibb Co. | 65.32B |
| Liquidia Corp. | 326.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 201.06B |
| Shareholders Equity (Quarterly) | 84.97B |
| Debt to Equity Ratio | 0.5771 |
| Current Ratio | 1.089 |
| Net Debt Paydown Yield | 0.11% |